• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Mazagon Dock
    2,750.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Hind.Aeronautics
    4,328.95 5,675.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • TCS
    3,396.10 3,396.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,764.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    652.80 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Angel One
    2,475.00 3,502.60(%)
  • Jio Financial
    231.75 394.70(%)
  • HDFC Bank
    1,776.70 1,430.15(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Reliance Power
    44.44 54.25(%)
  • Zomato Ltd
    208.35 146.85(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Emcure Pharma
    1,025.75 911.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kopran Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Parijat
  • BSE Code : 2717.0
  • ISIN : INE082A01010
196.18 5 (2.40%)
  • As on 03 Apr 2025 (EOD)
  • Today’s Low

    192.54
  • Today’s High

    198.87
  • Open

    193.98
  • Perv Close

    191.59
  • 52W Low

    156.01
  • 52W High

    369.70

Key Indicators

  • P/E(TTM)

    28.26

  • Mar.Cap (₹Cr.)

    947.27

  • Div & Yield %

    1.53

  • Book Value(₹)

    85.82

  • Debt-Equity Ratio

    2.40

  • AGM Date

    03-Apr-2025

  • EPS

    6.95

  • P/E Ratio

    28.26

Financials Ratios

  • Debt-Equity Ratio

    0.19

  • Mar.Cap (₹Cr.)

    947.27

  • RONW (%)

    10.95

  • ROCE (%)

    13.57

Score Board

  • Equity (₹ in Cr.)

    48.29

  • BV (₹)

    85.80

  • Sales( ₹ in Cr.)

    337.46

  • NP (in Cr.)

    34.64

  • NP Var(%)

    11.0

  • Div%

    30.0

  • CPS (₹)

    8.10

  • EPS (₹)

    7.20

  • Traded Value (₹ in Lakhs)

    948.33

  • 52 Week High

    369.70

  • 52 Week Low

    156.01

  • Price BSE

    196.0

  • Price NSE

    196.00

  • Market Capital( in Cr.)

    948.33

  • P/C Ratio

    24.10

  • P/E Ratio

    27.30

  • Price Vs.BV

    7.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 337.46 273.09 204.52 222.83 179.29 196.65
Excise Duty 331.49 268.89 203.36 217.43 173.76 191.26
Net Sales 337.46 273.09 204.52 222.83 179.29 196.65
Other Income 16.71 16.09 8.03 10.41 1.99 3.10
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 354.17 289.18 212.55 233.25 181.28 199.74
EXPENDITURE :
Raw Materials 331.49 268.89 203.36 217.43 173.76 191.26
Power & Fuel Cost 331.49 268.89 203.36 217.43 173.76 191.26
Employee Cost 25.61 25.15 21.05 18.34 20.02 20.38
Other Manufacturing Expenses 1.98 3.23 1.31 2.75 1.90 1.57
Selling & Administrative Expenses 22.45 20.85 22.65 19.79 19.54 19.32
Miscellaneous Expenses 1.98 3.23 1.31 2.75 1.90 1.57
Less : Pre-operative Expenses Capitalised :
Total Expenditure 309.65 252.27 196.38 200.54 165.55 182.38
Operating Profit 20.34 18.27 16.26 14.01 13.48 15.18
Interest 4.50 2.67 2.95 3.81 5.96 5.46
Gross Profit 44.52 36.92 16.16 32.71 15.73 17.36
Depreciation 4.62 4.41 4.32 4.10 3.47 3.11
Profit Before Tax 44.52 36.92 16.16 32.71 15.73 17.36
Tax 10.08 5.87 3.75 5.76 2.80 3.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 -0.21 0.67 3.48 1.71 0.91
Reported Net Profit 34.64 31.25 11.74 23.47 11.22 12.97
Extraordinary Items 44.52 36.92 16.16 32.71 15.73 17.36
Adjusted Net Profit 34.64 31.25 11.74 23.47 11.22 12.97
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 14.46 14.46 14.46 12.98 0.00 0.00
P & L Balance carried down 34.64 31.25 11.74 23.47 11.22 12.97
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 30.00 30.00 30.00 30.00 0.00 0.00
Dividend Per Share(Rs) 3.00 3.00 3.00 3.00 0.00 0.00
Earnings Per Share-Unit Curr 7.18 6.48 2.65 5.43 2.59 3.00
Book Value 14.46 14.46 14.46 12.98 0.00 0.00
Book Value(Adj)-Unit Curr 14.46 14.46 14.46 12.98 0.00 0.00

Shareholding Pattern

  • Promoter Group

    44.45%

  • Public Share Holding

    55.54%

  • Custodian

    0.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 16,377,693 33.94 16,377,693 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,071,510 10.51 5,071,510 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,449,203 44.45 21,449,203 19
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 300 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 416,978 0.86 416,978 27
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 300 0.00 0 3
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,516 0.00 1,016 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 419,394 0.87 418,294 39
2] Non Institution
Bodies Corporate 3,210,976 6.66 3,191,376 334
Clearing Members 134,695 0.28 134,695 31
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,885,299 3.91 1,885,149 904
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,193,553 2.47 1,193,553 1,339
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,466,480 7.18 3,466,480 63
Individuals holding nominal share capital up to Rs. 1 lakh 16,485,857 34.17 16,245,109 57,827
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,948 0.00 1,948 2
Others 1,500 0.00 1,500 1
Sub Total 26,380,308 54.67 26,119,810 60,501
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 500 0.00 500 1
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 500 0.00 500 1
Grand Total ( A + B + C ) 48,249,405 100.00 47,987,807 60,560

Company Background

Kopran LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kopran Ltd
  • BSE Code : 2717.0
  • ISIN : INE082A01010
  • Incorporation Year

    1958

  • Registered Office

    Parijat House 1076
    Dr E Moses Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-43661111

  • FAX

    91-22-24950363

  • Chairman

    Susheel Somani

  • Managing Director

  • Company Secretary

    Sunil Sodhani

  • Auditor

    Khandelwal Jain & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Kopran Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kopran 196.40 354.17 337.46 28.26 11.24
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92